THE NETWORK OF HOSPITAL PHARMACY SPECIALISATION SCHOOLS
The fi rst topic will cover the recently revised programme of the hospital pharmacy specialisation school, and will be explained by two pharmacists: Dr Paolo Serra (SIFO national coordinator for the schools of specialisation) and Dr Federica Locchi (a specialising pharmacist at the University of Bologna).
The 2009 school reform greatly changed the content and structure of the specialisation school: the programme was extended to 4 years, and breakdown between the time spent at the practice sites (eg, hospital pharmacies and outpatient pharmaceutical departments) and at the university favoured the fi rst, by a 70/30 ratio.
The postgraduate school student interacts at several levels: at the practice sites with the tutors and the hospital pharmacy director and at the university with the faculty and dean of the school of pharmacy.
In this context, it is essential to harmonise both university and practice programmes in order to ensure a homogeneous education all over the country. Moreover, close interaction between academics and practice is essential to ensure the multitask training aimed at educating an up to date hospital pharmacy specialist.
SIFO provides its support with the Scuole di Specializzazione in Farmacia Ospedaliera network, a web based tool that improves communication, cross talking and problem solving between directors, teachers, tutors and students of the different Italian schools. At present, fi ve out of 23 schools are testing the platform (Bologna, Genova, Novara, Bari and Siena).
The main aims of the project are:
▶ To harmonise programmes across universities ▶ To harmonise practice content among practice sites ▶ To promote multi-site and multi-school projects.
The main tasks of the platform are:
▶ Sharing class programmes and teaching materials ▶ Cross alerts on seminar and national events ▶ Forum on specifi c topics ▶ Tool for multicentre trials ▶ 'Benchmark' in professional formation ▶ National map of schools, hospitals and sanitary structures involved in the formation.
This dynamic network is also exportable in other European realities.
HEALTH TECHNOLOGY ASSESSMENT
Dr Valeria Fadda will describe the Italian experiences with health technology assessment (HTA), a multidisciplinary fi eld of policy analysis. SIFO, in the last 4 year programme, included HTA as one of the priority activities and it is supporting this important challenge for the development, diffusion and use of health technology in terms of economic outcomes also.
In recent times there has been a growing pressure to better manage healthcare expenditures and to balance opportunity costs and resource allocation. For this reason, HTA is increasingly being recognised in Italy as an essential tool for the decision making process, mostly at the regional level.
SIFO has long been engaged in the containment of healthcare expenditure by promoting both effi ciency and quality.
High risk medical devices are becoming an increasingly important focus of interest for both the Italian and European scientifi c communities because of the low level of regulation in this fi eld in the premarketing and postmarketing phases. The contribution of SIFO in this specifi c area is expressed through the 'across Italy project', a joint work among hospital pharmacists involved in evaluation of medical devices.
The aim of the project is to encourage economic and clinical evaluation of medical devices in order to ensure patient safety and allocate resources for safe and effective devices and, in addition, to share the evaluations with different hospitals.
The relevant items shared between the participating centres are mainly the local reimbursement price and a short evaluation report of the device. The form is a summary of the clinical, economic and general information about the device and it acts as an aid for local decision makers who are called on to decide on the governance of the specifi c device.
Currently, 20 centres joined the project and 43 evaluations have been made available. by patients (60% perceived the presence of the pharmacist in the ward, 50% of patients claim to have received advice about treatment, in 58% of cases the pharmacist had played an important role in counselling during hospitalisation) and good evaluation by health professionals (the pharmacist had a role in informing the drug (score 3.7 on a numerical scale from 1 to 4) according to medical opinion and he had a role (score 3.6) in preparation and conservation, based on nurses' opinions).
Apart from the numerical results, the relevance of the project was to defi ne a potential model of the ward pharmacist adapted to the Italian situation.
This project represents a fi rst step in the evolution of the hospital pharmacist's role which is now required to be an integral part of the healthcare team in order to support both the management of therapies and patient safety.
THE OUTPATIENT PHARMACEUTICAL SERVICES
Dr Ilaria Uomo will describe the role and tasks of the outpatient pharmaceutical services, the twin side of the hospital pharmacy of the public health system.
The Italian Health System operates through local health authorities which manage nearly 80% of small public hospitals. Pharmaceutical services are under the control of the local health units and are responsible for various matters related to drugs and medical devices, at the interface between the hospital and the community Educational requirements for pharmacists in the outpatient pharmaceutical services are the same as for hospitals (eg, they need hospital pharmacy specialisation).
Their activities can be classifi ed as: (a) towards patients: drug information, dispensing of specialist drugs; (b) towards general practitioners: prescription monitoring, as a guarantee of compliance with the Italian Medicine Agency guidelines; prescription surveillance as a measure of cost containment, in cooperation with various levels of institutions (local or regional); (c) towards community pharmacies: supervision (eg, certifi cations and payments for all drugs dispensed free of charge under the National Health Service regulations).
The pharmaceutical services are involved in larger processes or strategies with the aims of coordinating health services and professionals, building an ideal bridge between hospitals, community districts and territorial health structures (such as family counselling, primary care physicians, emergency medical services), preserving quality of life and reducing the costs of inappropriate treatments or hospitalisations.
As required by the programmes of the school of specialisation in hospital pharmacy, the pharmaceutical services are also involved in student on the job training. 
